The Precision Peptide Genetic Test from PlexusDx examines genetic variants including FTO rs9939609, which affect how your body responds to GLP-1 therapy at the cellular level
Critical limitations in the current evidence include: Most studies focus on surrogate markers (liver fat content, enzyme levels) rather than hard clinical outcomes (cirrhosis prevention, liver-related mortality) Long-term safety data beyond 12 years are generally unavailable Optimal patient selection criteria remain unclear Cost-effectiveness has not been established for liver-specific indications Patients should understand that promising research findings do not constitute proof of clinical benefit or justify off-label use outside properly conducted clinical trials or specialist supervision
Gastrointestinal Distress and Mental Well-being: The common gastrointestinal side effects of GLP-1 inhibitors, such as nausea, vomiting, and diarrhea, can indirectly impact mental health
Health reporter Katherine Ward has more from doctors about the rare condition, and what people taking the drug should know
It binds to hydrogen sulfide gas in your stomach and has antibacterial properties that reduce sulfur-producing bacteria
Glutathione treatment may be recommended for various skin types after a detailed consultation with a dermatologist